Tybost (Cobicistat) for HIV

Overview
Tybost is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in combination with antiretroviral medications. Tybost is also referred to by its drug name, Cobicistat, and by the abbreviation COBI. Cobicistat is a component in the combination medications Evotaz, Prezcobix, Genvoya, and Stribild. Tybost is a pharmacokinetic enhancer. Tybost is believed to work by preventing the body from breaking down some antiretroviral drugs, increasing their effectiveness.

How do I take it?
Prescribing information states that Tybost is taken once daily. Tybost comes in tablet form.

Side effects
The FDA-approved label for Tybost lists common side effects including jaundice and rash. Rare but serious side effects listed for Tybost include kidney failure.

For more details about this treatment, visit:

Tybost highlights of prescribing information – Gilead

Overview of HIV Treatments – AIDS.gov